JP MORGAN/PUT/FRESENIUS/22/0.1/20.12.24 Share Price

Warrant

DE000JS8KAA0

Market Closed - Börse Stuttgart 07:53:56 05/07/2024 BST
0.03 EUR +11.11% Intraday chart for JP MORGAN/PUT/FRESENIUS/22/0.1/20.12.24
Current month-11.76%
1 month-18.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/07/24 0.03 +11.11%
04/07/24 0.027 -6.90%
03/07/24 0.029 -12.12%
02/07/24 0.033 -8.33%
01/07/24 0.036 +5.88%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 07:53 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
Issuer J.P. Morgan
WKN JS8KAA
ISINDE000JS8KAA0
Date issued 08/03/2023
Strike 22
Maturity 20/12/2024 (168 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.36
Lowest since issue 0.027
Delta-0.09x
Omega 8.201
Premium25.46x
Gearing93.87x
Moneyness 0.7560
Difference Strike -7.1
Difference Strike %-32.27%
Spread 0.01
Spread %27.78%
Theoretical value 0.0310
Implied Volatility 35.27 %
Total Loss Probability 86.83 %
Intrinsic value 0.000000
Present value 0.0310
Break even 21.69 €
Theta-0x
Vega0x
Rho-0x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.1 EUR
Average target price
37.26 EUR
Spread / Average Target
+28.03%
Consensus